Predictors of mortality among patients with community-onset infection due to extended-spectrum β-lactamase-producing Escherichia coli in Thailand

Infection Control and Hospital Epidemiology

Volumn 29, Issue 1, 2008, Pages 80-82

  Apisarnthanarak, Anucha ^a   Kiratisin, Patarachai ^b   Saifon, Piyawan ^b   Kitphati, Rungrueng ^c   Dejsirilert, Surang ^c   Mundy, Linda M ^d  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Thai National Institute of Health   (Thailand)

^d SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; COMMUNITY ONSET INFECTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; MALE; MORTALITY; MULTIVARIATE ANALYSIS; STATISTICAL SIGNIFICANCE; THAILAND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; THAILAND;

EID: 39449136560     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/524321     Document Type: Article

References (10)

1. Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended-spectrum β-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004; 23:163-167.
2. Calbo E, Romaný V, Xercavins M, et al. Risk factors for communityonset urinary tract infections due to Escherichia coli harboring extendedspectrum β-lactamases. J Antimicrob Chemother 2005; 57:780-783.
3. Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM. Clinical and molecular epidemiology of community-onset extended spectrum β-lactamase producing Escherichia coli in Thailand: a case-case-control study. Am J Infect Control 2007; 35:606-612.
4. Rodriguez-Bano J, Navarro MD, Romero L, et al. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006; 43:1407-1414.
5. Dejsirilert S, Apisarnthanarak A, Kitphati R, et al. The status of antimicrobial resistance in Thailand among gram-negative pathogens in bloodstream infections: NARST data, 2000-2003. In: Program and abstracts of the 9th Western Pacific Congress on Chemotherapy and Infectious Diseases (Bangkok). 2004: 185 (Abstract FP-A-3).
6. Apisarnthanarak A, Danchaivijitr S, Bailey TC, et al. Inappropriate antibiotic use in a tertiary care center in Thailand: an incidence study and review of experience in Thailand. Infect Control Hosp Epidemiol 2006; 27:416-420.
7. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140.
8. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31(suppl 4):S131-S138.
9. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement. Wayne, PA: CLSI; 2006:M100-S16.
10. Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli. Clin Infect Dis 2002; 34:1558-1563.